Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 478841 - 478860 out of 495978 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (A10BD16) metformin and canagliflozin | INVOKAMET XR TABS 50/500MG | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Johnson&JohnsonHealthCareSystems,Inc.oboJanssenPharmaceuticals,Inc |
| USA | (A10BD19) linagliptin and empagliflozin | TRIJARDY XR 10MG/5MG/1000MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | TRIJARDY XR 10MG/5MG/1000MG | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | TRIJARDY XR 12.5MG/2.5MG/1000MG | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | TRIJARDY XR 12.5MG/2.5MG/1000MG | 180 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | TRIJARDY XR 25MG/5MG/1000MG | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | TRIJARDY XR 25MG/5MG/1000MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | TRIJARDY XR 5MG/2.5MG/1000MG | 180 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | TRIJARDY XR 5MG/2.5MG/1000MG | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | GLYXAMBI 10MG/5MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Diabetes Mellitus, Type 2 | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | GLYXAMBI 10MG/5MG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Diabetes Mellitus, Type 2 | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | GLYXAMBI 10MG/5MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Diabetes Mellitus, Type 2 | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | GLYXAMBI 10MG/5MG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Diabetes Mellitus, Type 2 | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | GLYXAMBI 25MG/5MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Diabetes Mellitus, Type 2 | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | GLYXAMBI 25MG/5MG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Diabetes Mellitus, Type 2 | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | GLYXAMBI 25MG/5MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Diabetes Mellitus, Type 2 | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | GLYXAMBI 25MG/5MG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Diabetes Mellitus, Type 2 | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | GLYXAMBI/10MG/5MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Diabetes Mellitus, Type 2 | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | GLYXAMBI/10MG/5MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Diabetes Mellitus, Type 2 | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (A10BD19) linagliptin and empagliflozin | GLYXAMBI/25MG/5MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Diabetes Mellitus, Type 2 | BoehringerIngelheimPharmaceuticals,Inc. |
Pages
